Infarction, Middle Cerebral Artery - Metabolism
Research News and Information

Sunday, November 22, 2009

Astrocytes are more resistant to focal cerebral ischemia than neurons and die by a delayed necrosis.

29 Sep 2009 Several recent reports proposed that astrocyte death might precede neuronal demise after focal ischemia, contrary to the conventional view that astrocytes are more resistant to injury than neurons. Interestingly, there are findings supporting each ... Read more...

A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis.

21 Sep 2009 BACKGROUND: Phospholipase A2 liberates free fatty acids and lysophospholipids upon hydrolysis of phospholipids and these products are often associated with detrimental effects such as inflammation and cerebral ischemia. The neuroprotective effect of ... Read more...

Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.

28 Jul 2009 BACKGROUND AND PURPOSE: The importance of bioactive lipid signaling under physiological and pathophysiological conditions is progressively becoming recognized. The disparate distribution of sphingosine kinase (SphK) isoform activity in normal and ... Read more...

Latest indexed articles for 'Infarction, Middle Cerebral Artery - Metabolism'

These are the very latest articles for this heading:

• Astrocytes are more resistant to focal cerebral ischemia than neurons and die by a delayed necrosis. 29 Sep 2009
• A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis. 21 Sep 2009
• Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. 28 Jul 2009
• Separable detection of lipophilic- and hydrophilic-phase free radicals from the ESR spectrum of nitroxyl radical in transient MCAO mice. 18 Jul 2009
• Temporal changes in expression of aquaporin-3, -4, -5 and -8 in rat brains after permanent focal cerebral ischemia. 14 Jul 2009
• Nitroxyl exacerbates ischemic cerebral injury and oxidative neurotoxicity. 6 Jul 2009
• Galectin-3 mediates post-ischemic tissue remodeling. 28 Jun 2009
• Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. 23 Jun 2009
• Noninvasive assessment of the brain redox status after transient middle cerebral artery occlusion using Overhauser-enhanced magnetic resonance imaging. 22 Jun 2009
• Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. 26 May 2009
• Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. 20 May 2009
• Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. 12 May 2009
• Longitudinal changes of defensive and offensive factors in focal cerebral ischemia-reperfusion in rats. 12 May 2009
• eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice. 12 May 2009
• Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. 11 May 2009
• Bone marrow stromal cells increase oligodendrogenesis after stroke. 20 Apr 2009
• Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. 7 Apr 2009
• Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. 5 Apr 2009
• When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats. 23 Mar 2009
• Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA. 23 Mar 2009

See a longer list of these articles.

Technical information about 'Infarction, Middle Cerebral Artery'

Definition: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Descriptor UI: D020244

Alternative terms: Infarction, Middle Cerebral Artery; MCA Infarction; Middle Cerebral Artery Circulation Infarction; Middle Cerebral Artery Stroke; Stroke, Middle Cerebral Artery; Cerebral Infarction, Middle Cerebral Artery; Middle Cerebral Artery Infarction; Left Middle Cerebral Artery Infarction; Middle Cerebral Artery Embolus; Embolus, Middle Cerebral Artery; Middle Cerebral Artery Occlusion; Occlusion, Middle Cerebral Artery; Thrombotic Infarction, Middle Cerebral Artery; Middle Cerebral Artery Thrombotic Infarction; Middle Cerebral Artery Thrombosis; Thrombosis, Middle Cerebral Artery; Right Middle Cerebral Artery Infarction; Embolic Infarction, Middle Cerebral Artery; Middle Cerebral Artery Embolic Infarction; Middle Cerebral Artery Syndrome;

Related Mesh Headings: Infarction;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.228.140.300.150.477.200.450; C10.228.140.300.510.200.387; C10.228.140.300.775.200.200.450; C14.907.253.092.477.200.450; C14.907.253.560.200.387; C14.907.253.855.200.200.450;

History Note: 2000